leisure time -WSS

leisure time

author：hotspot 2025-10-02 22:57:50 - browse：5691

Illustration of a person holding a phone with apps and small people (patients and doctors) on the screen. -- chronic disease coverage from STAT — Molly Ferguson for STAT

If her neurologist moved to China, Lauren Stiles says she’d follow him there. “There’s so few doctors who do this,” said the New York-based president of patient advocacy group Dysautonomia International.

In her world, informed, experienced specialists — particularly in the autonomic nervous system — are extremely rare. Telehealth can open doors for patients who have been searching for a doctor who understands them. Stiles had to travel hundreds of miles to find an expert at the Cleveland Clinic who could diagnose her (it took two years to figure out she has postural orthostatic tachycardia syndrome, or POTS, and Sjögren’s syndrome). When that last-ditch doctor moved to Virginia, she followed him.

But many times, Stiles has questions that shouldn’t take a dozen-hour road trip to answer. She’d love to call him up and have an appointment over the phone.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Wegovy trial has doctors encouraged over new possibilities

focus

WSS

Startling documents reveal new facets of Sacklers' opioid empire

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

South Korea throws huge K

David Sabatini, ex

A biotech analyst on neuroscience, placebo effect, not over

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Activists slam private health insurers over coverage restrictions

What to know about Virgin Galactic's 1st mission taking paying customers to space

Anesthesiologist group: stop taking Ozempic before surgery

Scientists successfully use ultrasound imaging to map brain activity

Apple is now the first public company to be valued at $3 trillion

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

At least 13 dead in Texas as scorching temps continue

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Trump demands the U.S. pay no more for drugs than other countries … again

Friends ask where James Watson's attitudes about race came from

focus

Wegovy’s successful heart trial raises vital question about weight loss

Emergent cuts jobs, executive role in business shake

Why failed clinical trials don’t always spell doom for a new drug

Police still searching for prisoner who escaped from NYC hospital

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Anavex keeps shifting the goalposts in its clinical trials

knowledge

focus

Wikipedia

Wikipedia